FORE to Host Webinar on Medicaid’s Pivotal Role in the U.S. Response to the Opioid Crisis
19 mars 2025 09h51 HE
|
Foundation for Opioid Response Efforts
New York, March 19, 2025 (GLOBE NEWSWIRE) -- The Foundation for Opioid Response Efforts (FORE) is hosting a webinar on “Medicaid’s Ongoing Critical Role in the U.S. Response to the Opioid and...
Foundation for Opioid Response Efforts Awards Grant to Tradeoffs to Expand Reporting on Opioid and Overdose Crisis
13 mars 2025 10h30 HE
|
Foundation for Opioid Response Efforts
New York, March 13, 2025 (GLOBE NEWSWIRE) -- The Foundation for Opioid Response Efforts (FORE) has awarded a $65,702 grant to Tradeoffs, a nonprofit health care news organization, to support new...
Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals
14 janv. 2025 07h30 HE
|
Emergent BioSolutions
Alongside over-the-counter NARCAN® Nasal Spray 4 mg, prescription KLOXXADO® (naloxone HCl) Nasal Spray 8 mg will expand Emergent’s ability to distribute multiple life-saving opioid overdose emergency...
2024 Learning Series Drives Conversations and Solutions in the Fight Against Opioid Misuse
17 déc. 2024 10h33 HE
|
Partnership for a Drug-Free New Jersey
Millburn, NJ, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Thousands of residents from New Jersey and throughout the country, including many health care professionals, are now better informed and prepared to...
FFF Enterprises, Inc. Launches ODRescue™ Life-Saving Opioid Overdose Rapid Response Tools
10 déc. 2024 13h34 HE
|
FFF Enterprises.com
TEMECULA, Calif, Dec. 10, 2024 (GLOBE NEWSWIRE) -- FFF Enterprises, Inc., recognized as the nation's most trusted specialty drug distributor and diversified healthcare company, announces the launch...
FORE Allocates $2.4 Million to Combat Overdose and Opioid Crisis Among Vulnerable Populations
10 déc. 2024 10h09 HE
|
Foundation for Opioid Response Efforts
New York, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The opioid and overdose crisis continues to exact a heavy toll on at-risk populations across the United States. Among adolescents aged 13-18, overdose...
Spark Biomedical Sets Sights on Global Expansion with New ISO 13485 and MDSAP Certifications
18 nov. 2024 10h48 HE
|
Spark Biomedical
Dallas, TX, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Spark Biomedical, a leading developer of wearable neurostimulation devices, proudly announces the recent achievement of ISO 13485:2016 and MDSAP Quality...
Statement on Fentanyl “Exposure” Laws Issued by the American College of Medical Toxicology
04 nov. 2024 11h57 HE
|
American College of Medical Toxicology
Phoenix, AZ, Nov. 04, 2024 (GLOBE NEWSWIRE) -- In the recently issued, “Statement on Fentanyl “Exposure” Laws,” the American College of Medical Toxicology (ACMT) expresses concern regarding...
Communities Across New Jersey Rally for Ninth Annual Knock Out Opioid Abuse Day
31 oct. 2024 11h05 HE
|
Partnership for a Drug-Free New Jersey
Millburn, NJ, Oct. 31, 2024 (GLOBE NEWSWIRE) -- New Jersey organizations, law enforcement representatives and residents united earlier this month to educate their communities about the opioid...
Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic
08 oct. 2024 17h32 HE
|
Emergent BioSolutions
Ongoing support of the ‘White House Challenge to Save Lives from Overdose’ through workplace and public safety measuresOne-year mark of Ready to Rescue public awareness campaign to expand awareness,...